SCHEMBL30746686

SCHEMBL30746686

OCc1cncc(Nc2ccc(Cl)cc2F)c1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 3/20 0.43
▸ KMT2A Q03164 2/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ TRPM5 Q9NZQ8 1/20 0.36
▸ MAP2K1 Q02750 2/20 0.35
▸ KDR P35968 6/20 0.35
▸ FLT1 P17948 4/20 0.35
▸ EGFR P00533 3/20 0.35
▸ PDGFRB P09619 1/20 0.35
▸ FGFR1 P11362 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ CYP3A5 P20815 1/20 0.33
▸ VNN1 O95497 1/20 0.33
▸ CSF1R P07333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26985203 1.00 NUDT1 (0.43) NUDT1KMT2ACNR2TRPM5MAP2K1
SCHEMBL30746436 0.88 NUDT1 (0.40) NUDT1KMT2ACNR2TRPM5KDR
SCHEMBL26985312 0.88 NUDT1 (0.40) NUDT1KMT2ACNR2TRPM5KDR
SCHEMBL26985139 0.82 NUDT1 (0.47) NUDT1KMT2ATRPM5MAP2K1KDR
SCHEMBL30746528 0.82 NUDT1 (0.47) NUDT1KMT2ATRPM5MAP2K1KDR
SCHEMBL26985321 0.79 NUDT1 (0.53) NUDT1KMT2ACNR2MAP2K1CSF1R
SCHEMBL30746391 0.79 NUDT1 (0.53) NUDT1KMT2ACNR2MAP2K1CSF1R
SCHEMBL30746627 0.78 NUDT1 (0.39) NUDT1KMT2ACNR2TRPM5MAP2K1
SCHEMBL26985082 0.78 NUDT1 (0.39) NUDT1KMT2ACNR2TRPM5MAP2K1
SCHEMBL30746560 0.76 NUDT1 (0.53) NUDT1CNR2MAP2K1KDRFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback